Experimental and Computational analysis for linking infection dynamics and lung pathology in COVID-19 (ExComPat-COVID19)
- Funded by Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)
- Total publications:0 publications
Grant number: 01KI20239A 01KI20239B 01KI20239C
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$284,934.1Funder
Bundesministerium für Bildung und Forschung [German Federal Ministry of Education and Research] (BMBF)Principal Investigator
Dr and Prof Dr and Dr Frederi Graw, Rocio Sotillo, Megan StaniferResearch Location
GermanyLead Research Institution
Ruprecht-Karls Universität Heidelberg, Deutsches Krebsfoschungszentrum, Heidelberg, Ruprecht-Karls-Universität HeidelbergResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The infection dynamics of SARS-CoV-2 within the lung and its association with disease progression is still incompletely understood. To which extent viral replication kinetics and virus-associated tissue pathology determine patient outcome remains an open question that is of urgent importance to advise effective treatment strategies. In this project, we will combine experimental data of lung organoids with detailed mathematical and computational models to assess SARS-CoV-2 infection kinetics under physiologically relevant conditions. By integrating spatially-resolved microscopy images with time course infection data of SARS-CoV-2 in lung organoids by mathematical analyses we will be able to quantify key parameters governing viral replication and spread, and their association with pathological changes. Extending the computational model to extrapolate infection dynamics within a human lung, we will be able to relate observed viral load kinetics in SARS-CoV-2 infected patients to expected tissue pathology and disease progression. This will help to assess the significance of viral load levels for associated lung pathology during infection. Our interdisciplinary approach will improve our understanding of SARS-CoV-2 replication and spread within lung tissue and its association with disease progression. Furthermore, the inferred computational model provides a tool to test the efficacy of antiviral therapies and represents a first step towards a mechanistic model of infection progression within tissue that could improve our understanding of individual patient outcome.